Chronic Migraines and Neurofdeeback Mindfulness
Unknown statusNot applicableNCT06342219
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.
Study details
- Official title
- Study Protocol for a Randomized Controlled Trial of Neurofeedback Mindfulness in Chronic Migraines
- Conditions
- Interventions
- Behavioral: Neurofeedback Mindfulness
- Behavioral: Attention Task
- Sponsor
- University of Saskatchewan
- Collaborators
- Saskatchewan Health Research Foundation
- Start date
- 2024-12
- Primary completion
- 2025-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * have a diagnosis of chronic migraine from a clinician or have met the criteria for a chronic migraine diagnosis based on ICHD-3 * reside in Saskatoon area * have a smartphone and internet connection for accessing the MUSE app * have no frequent background experience of meditation Exclusion Criteria: * Comorbidity of Raynaud's syndrome or diabetes * Current use of a preventative migraine treatment over 6 months
Canadian sites (1)
| Facility | City | Province |
|---|---|---|
| University of Saskatchewan | Saskatoon | Saskatchewan |
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06342219